Home | Articles
Published on:July 2019
Indian Journal of Pharmaceutical Education and Research, 2019; 53(3):355-365
Review Article | doi:10.5530/ijper.53.3.69

Development and Application of Lipid Nanotechnology on Infectious Diseases of CNS- Current Scenario

Authors and affiliation (s):

Swarupanjali Padhi1,*, Rupa Mazumder1, Shradha Bisth2

1Pharmacy Institute, Noida Institute of Engineering and Technology, Greater Noida, Gautam Buddha Nagar, Uttar Pradesh, INDIA.

2Department of Pharmacy, Sardar Bhagwan Singh Post Graduate Institute of Biomedical Science and Research, Balawala, Dehradun, Uttarakhand, INDIA.


Background: This is an era of inventive technology illuminating fundamental mechanisms of diseases and fabricating drug molecules according to prerequisite condition, but it is still a challenge to target infectious diseases specially in CNS due to various restrictions of drug delivery to the brain and drawbacks of various conventional antimicrobial agents. These are prone to development of multiple drug resistances as sufficient amount of drug cannot reach to the site of infection. Materials and Methods: This review summarizes the problems associated with the amount of drug delivered to CNS and the emergence of new tools like lipid nanoparticles to deal with the current challenges in treating infectious diseases of CNS. Results: This article discusses the anatomical and physiological barriers of CNS and development of various drug delivery system, specially the development of lipid nanoparticles including solid lipid nanoparticles, nanostructured lipid carriers, lipid drug conjugated nanoparticles to address the challenges. Conclusion: This article is an extensive review on current status of drug therapy of infectious diseases of CNS. Lipid nanoparticles like SLN and NLCs have proven to be effective tools for improved drug delivery to CNS and PNS.

Key words: Multiple drug resistance, Solid lipid nanoparticles, Nanostructured lipid carriers, Lipid drug conjugated nanoparticles, CNS, Blood-brain barrier.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).


Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs